Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Amortizatization of Intangibles (2024 - 2025)

Kairos Pharma (KAPA) has disclosed Amortizatization of Intangibles for 2 consecutive years, with $40000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Amortizatization of Intangibles changed 0.0% year-over-year to $40000.0, compared with a TTM value of $160000.0 through Jun 2025, changed N/A, and an annual FY2024 reading of $160000.0, changed 0.0% over the prior year.
  • Amortizatization of Intangibles was $40000.0 for Q2 2025 at Kairos Pharma, roughly flat from $40000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $74000.0 in Q3 2024 and bottomed at $6000.0 in Q4 2024.